Search results for "MESH : Humans"

showing 10 items of 113 documents

Long-Term Clinical Outcomes According to Previous Manifestations of Atherosclerotic Disease (from the FAST-MI 2010 Registry)

2017

IF 3.398; International audience; The prognosis of patients with acute myocardial infarction (AMI) has notably improved in the past 20 years. Using the French Registry of ST-Elevation and Non-ST-elevation Myocardial Infarction (FAST-MI) 2010 registry, we investigated whether previous manifestations of atherosclerotic disease (i.e., previous MI, or a history of any form of atherosclerotic disease) are at truly increased risk compared with those in whom AMI is the first manifestation of the disease. FAST-MI 2010 is a nationwide French registry including 3,079 patients with AMI, among whom 1,062 patients had a history of cardiovascular atherosclerotic disease and 498 patients had a history of …

MaleMESH : Atherosclerosismedicine.medical_treatmentMESH : MortalityMyocardial InfarctionMESH : AgedMESH : Prospective StudiesAngiotensin-Converting Enzyme InhibitorsCoronary Artery DiseaseDiseaseMESH : Cerebrovascular Disorders0302 clinical medicineMedicineLongitudinal StudiesProspective StudiesMESH: Coronary Artery DiseaseMyocardial infarctionCoronary Artery BypassMESH: Treatment OutcomeCause of deathAged 80 and overeducation.field_of_studyMESH: Middle AgedHazard ratioMESH : Platelet Aggregation InhibitorsPrognosisMESH: Case-Control Studies3. Good healthMESH: Myocardial InfarctionMESH: Angiotensin Receptor AntagonistsMESH : Angiotensin-Converting Enzyme InhibitorsCardiology and Cardiovascular MedicineMESH: Percutaneous Coronary InterventionMESH : Case-Control Studiesmedicine.medical_specialtyMESH : Angiotensin Receptor AntagonistsMESH: Prognosis03 medical and health sciencesPercutaneous Coronary Intervention[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemHumansMESH : Middle AgedMESH : Coronary Artery DiseaseMESH : Aged 80 and overMESH: Hydroxymethylglutaryl-CoA Reductase InhibitorseducationMESH: Age DistributionAgedMESH: HumansMESH: MortalityProportional hazards modelMESH: Coronary Artery BypassMESH : HumansCase-control studyMESH : Proportional Hazards Modelsmedicine.diseaseMESH : Coronary Artery BypassCase-Control StudiesMESH: FemaleMESH: RegistriesMESH : Age Distribution030204 cardiovascular system & hematologyMESH: AtherosclerosisMESH: Proportional Hazards ModelsMESH: Cause of DeathMESH: Aged 80 and overMESH : Percutaneous Coronary InterventionRisk FactorsMESH: Risk FactorsCause of DeathMESH : FemaleRegistries030212 general & internal medicineMESH: Longitudinal StudiesMESH : Longitudinal StudiesMESH: AgedMESH : PrognosisMESH: Angiotensin-Converting Enzyme InhibitorsMESH: Adrenergic beta-AntagonistsMiddle Aged[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemMESH : Risk FactorsTreatment OutcomeMESH: Platelet Aggregation InhibitorsCardiologyFemaleMESH: Cerebrovascular DisordersFranceMESH : MaleAdrenergic beta-AntagonistsMESH : Adrenergic beta-AntagonistsPopulationMESH : Treatment OutcomeMESH: Multivariate AnalysisAngiotensin Receptor AntagonistsAge DistributionInternal medicineMortalityMESH : FranceProportional Hazards ModelsMESH : Cause of Deathbusiness.industryMESH : Hydroxymethylglutaryl-CoA Reductase InhibitorsMESH : Multivariate AnalysisPercutaneous coronary interventionAtherosclerosisMESH: MaleMESH: Prospective StudiesMESH: FranceCerebrovascular DisordersMultivariate AnalysisHydroxymethylglutaryl-CoA Reductase InhibitorsMESH : Myocardial InfarctionbusinessPlatelet Aggregation InhibitorsMESH : RegistriesThe American Journal of Cardiology
researchProduct

CTX-M β-Lactamase-Producing Escherichia coli in French Hospitals: Prevalence, Molecular Epidemiology, and Risk Factors▿

2007

ABSTRACT In 2004, 65 CTX-M-producing Escherichia coli isolates were collected from infected patients in four French hospitals. The bla CTX-M-15 genes were predominant. Pulsed-field gel electrophoresis highlighted a clonal propagation of CTX-M-15-producing strains belonging to phylogenetic group B2, notably in the community. The main risk factors for acquiring these isolates were urinary tract infections or the presence of a urinary catheter in diabetic or renal failure patients.

MaleMESH : Escherichia coliMESH : PrevalenceEpidemiologyMESH : AgedMESH: beta-LactamasesMESH: Urinary Tract Infectionsmedicine.disease_causeMESH: Risk Factors[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesRisk FactorsGenotypePrevalenceMESH : Urinary Tract InfectionsMESH : FemaleMESH: PhylogenyEscherichia coli InfectionsPhylogenyGel electrophoresisMESH: Aged0303 health sciencesMolecular EpidemiologybiologyMESH: Escherichia coliMESH : beta-LactamasesMESH: HospitalsEnterobacteriaceaeMESH : Risk FactorsHospitals3. Good healthElectrophoresis Gel Pulsed-FieldMESH : Hospitals[ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesMESH: Electrophoresis Gel Pulsed-FieldMESH : Escherichia coli InfectionsUrinary Tract Infections[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesFemaleFranceMicrobiology (medical)Urinary systemMESH : Malebeta-LactamasesMicrobiologyMESH : Epidemiology Molecular03 medical and health sciencesMESH: Epidemiology MolecularmedicineEscherichia coliHumansRisk factorMESH : FranceEscherichia coliMESH: Prevalence030304 developmental biologyMESH : Electrophoresis Gel Pulsed-FieldMESH: Escherichia coli InfectionsAgedMESH: HumansMolecular epidemiology030306 microbiologyMESH : HumansMESH : Phylogenybiology.organism_classificationMESH: MaleMESH: FranceMESH: FemaleBacteria
researchProduct

VEB-1 in Achromobacter xylosoxidans from Cystic Fibrosis Patient, France

2006

Multidrug-resistant Achromobacter xylosoxidans was recovered from the sputum of a patient with cystic fibrosis. The VEB-1 extended-spectrum β-lactamase was detected on a class 1 integron. This first report of a VEB-1–producing isolate in this population requires further investigation to determine its distribution.

MaleMESH : Molecular Sequence DataintegronMESH: beta-Lactamaseslcsh:MedicineMESH: Base Sequence[ SDV.MP.BAC ] Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyIntegronCystic fibrosisIntegronscystic fibrosisComputingMilieux_MISCELLANEOUSMESH: Microbial Sensitivity Tests0303 health scienceseducation.field_of_studybiologyEscherichia coli ProteinsMESH : beta-LactamasesAchromobacter denitrificansdispatchAchromobacter xylosoxidansMESH: Integrons3. Good healthMESH : Achromobacter denitrificansFrancemedicine.symptomAchromobacter xylosoxidansMESH : IntegronsMESH: Cystic FibrosisAdolescentMESH : MaleMolecular Sequence DataPopulationMicrobial Sensitivity Testsbeta-LactamasesMicrobiologylcsh:Infectious and parasitic diseases03 medical and health sciencesMESH : AdolescentMESH : Cystic FibrosismedicineHumansBase sequencelcsh:RC109-216education030304 developmental biologyMESH: AdolescentMESH: HumansMESH: Molecular Sequence DataBase Sequence030306 microbiologybusiness.industryMESH : Humanslcsh:RExtended-spectrum beta-lactamase VEB-1biology.organism_classificationmedicine.disease[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyMESH: MaleMESH: Achromobacter denitrificansAchromobacter denitrificansbiology.proteinSputumMESH : Base SequenceMESH : Microbial Sensitivity Tests[SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologybusinessEmerging Infectious Diseases
researchProduct

Trains with a view to sickness

2001

This study was supported by Region Rhone-Alpes (contract ARASSH n°L099552501) and CEC Improving Human Potential: Access to Research Infrastructures HPRI-1999-CT-00025.

MaleMESH : MotionMESH: GravitationMESH: Motion SicknessMESH : GravitationMESH : Railroads0302 clinical medicineMESH : FemaleMESH: RailroadsComputingMilieux_MISCELLANEOUSMESH: Middle AgedAgricultural and Biological Sciences(all)05 social sciencesMESH : AdultMiddle AgedMESH : Motion SicknessEuropeVisual Perception[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]TrainFemaleGeneral Agricultural and Biological SciencesMESH : Visual PerceptionGravitationAdultMotion SicknessMESH: MotionMESH : MaleMESH : EuropeBiology050105 experimental psychologyGeneral Biochemistry Genetics and Molecular BiologyTransport engineering03 medical and health sciencesMotionHumans0501 psychology and cognitive sciencesMESH : Middle Aged[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]RailroadsMESH: HumansMESH: Visual PerceptionBiochemistry Genetics and Molecular Biology(all)MESH : HumansMESH: AdultMESH: Male[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]MESH: EuropeMESH: Female030217 neurology & neurosurgeryCurrent Biology
researchProduct

Discrete and effortful imagined movements do not specifically activate the autonomic nervous system.

2009

International audience; BACKGROUND: The autonomic nervous system (ANS) is activated in parallel with the motor system during cyclical and effortful imagined actions. However, it is not clear whether the ANS is activated during motor imagery of discrete movements and whether this activation is specific to the movement being imagined. Here, we explored these topics by studying the baroreflex control of the cardiovascular system. METHODOLOGY/PRINCIPAL FINDINGS: Arterial pressure and heart rate were recorded in ten subjects who executed or imagined trunk or leg movements against gravity. Trunk and leg movements result in different physiological reactions (orthostatic hypotension phenomenon) whe…

MaleMESH : MovementPhysiologyBlood PressureMESH: MovementElectromyographyMESH : Autonomic Nervous SystemMESH: Autonomic Nervous SystemOrthostatic vital signs0302 clinical medicineHeart RateNervous System Physiological PhenomenaMESH: Heart RateMESH: Nervous System Physiological Phenomena0303 health sciencesNeuroscience/Behavioral NeuroscienceMultidisciplinarymedicine.diagnostic_testMovement (music)QRMESH: Blood PressureAnatomyMESH : AdultMESH : Nervous System Physiological PhenomenaMESH : ElectromyographyMedicine[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Research ArticleAdultScienceMovementMESH : MaleBaroreflexBiologyAutonomic Nervous SystemMESH: Electromyography03 medical and health sciencesMotor imageryMotor systemmedicineMESH : Blood PressureHumans[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]030304 developmental biologyNeuroscience/Cognitive NeuroscienceMESH: HumansElectromyographyMESH : Heart RateMESH : HumansMESH: AdultTrunkMESH: MaleAutonomic nervous system[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Neuroscience030217 neurology & neurosurgeryNeuroscience
researchProduct

Smoking and FOS expression from blood leukocyte transcripts in patients with coronary artery disease.

2011

International audience; OBJECTIVE: Analysis of the leukocyte transriptome, in particular the Finkel-Biskis-Jinkins Osteosarcoma (c-Fos) gene, which has a prominent role in inflammation, provides new insights into atherosclerosis mechanisms. Although smoking is a major risk factor, the links between smoking status and coronary artery disease (CAD) remains unclear. We aimed to analyze the relationship between smoking status and c-Fos expression in circulating leukocytes of patients with CAD. METHODS: c-Fos expression was measured by RT-Q-PCR, from blood leukocytes of 239 consecutive patients after acute myocardial infarction (MI). The patients were asked about their smoking status and stratif…

MaleMESH : RNA MessengerMESH: Chi-Square DistributionMESH : LeukocytesMESH : Prospective StudiesMESH : AgedMyocardial InfarctionSmoking PreventionMESH: Risk Assessmentc-FosMESH : Coronary Angiography0302 clinical medicineMESH : Genetic MarkersProspective StudiesMESH: Coronary Artery DiseaseAged 80 and over0303 health sciencesMESH: Middle AgedGenes fosMESH: Smoking Cessation3. Good healthMESH : SmokingMESH: Myocardial InfarctionOsteosarcomaSmoking statusCardiology and Cardiovascular MedicineGenetic Markersmedicine.medical_specialtyRisk AssessmentMESH: Leukocytes03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemHumansMESH : Middle AgedRNA MessengerMESH : Coronary Artery DiseaseRisk factorMESH : Aged 80 and overAgedChi-Square DistributionMESH: HumansMESH : Chi-Square DistributionMESH : Smoking CessationMESH : Humansmedicine.diseaseMESH: Coronary AngiographyLinear ModelsMESH: FemaleBlood leukocyte transcriptomeMESH : Genes fos030204 cardiovascular system & hematologyMESH: Genetic MarkersBioinformaticsCoronary AngiographyCoronary artery diseaseMESH: Linear ModelsCoronary artery diseaseMESH: Aged 80 and overRisk FactorsMESH: Risk FactorsMESH : Linear ModelsLeukocytesMESH : FemaleMESH : Risk AssessmentMESH: Agedc-FosbiologySmoking[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemMiddle AgedMESH : Risk Factors[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemCardiologyFemaleFrancemedicine.symptomInflammation MediatorsMESH: SmokingMESH : MaleMESH: Inflammation MediatorsInflammationMESH: Genes fosMESH: Multivariate AnalysisMESH : Inflammation MediatorsInternal medicinemedicineIn patientMESH : France030304 developmental biologyMESH: RNA Messengerbusiness.industryMESH : Multivariate AnalysisMESH: MaleMESH: Prospective StudiesMESH: FranceMultivariate Analysisbiology.proteinSmoking CessationMESH : Myocardial Infarctionbusiness
researchProduct

Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI study.

2016

IF 2.271; International audience; Background. - Clinical studies have shown a beneficial effect of cardiac rehabilitation (CR) on mortality.Objective. - To study the effect of CR prescription at discharge on 5-year mortality in patients with acute myocardial infarction (AMI).Methods. - Participants, from the 2005 French FAST-MI hospital registry, were 2894 survivors at discharge, divided according to AMI type: ST-segment elevation myocardial infarction (STEMI; n=1523) and non-STEMI (NSTEMI; n=1371). The effect of CR prescription on mortality was analysed using a Cox proportional hazards model.Results. - At discharge, 22.1% of patients had a CR prescription. Patients referred to CR were youn…

MaleMESH: Chi-Square Distributionmedicine.medical_treatmentMESH : Acute Coronary SyndromeMyocardial InfarctionMESH : AgedMESH : Prospective StudiesCardiac rehabilitationMESH: Risk Assessment0302 clinical medicineMyocardial infarctionProspective StudiesReferral and ConsultationMESH: Treatment OutcomeRehabilitationMESH: Middle AgedGeneral MedicineMESH: Follow-Up Studies3. Good healthMESH: Myocardial InfarctionMESH : Patient DischargeCardiology and Cardiovascular Medicinemedicine.medical_specialtyAcute myocardial infarctionMortalitéRisk Assessment03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemHumansMESH : Middle AgedAcute Coronary SyndromeMESH: Kaplan-Meier EstimateAgedChi-Square DistributionMESH: HumansMESH : Chi-Square DistributionProportional hazards modelMESH: Patient DischargeMESH : HumansPatient survivalMESH : Follow-Up Studiesmedicine.diseaseMESH : Proportional Hazards ModelsMESH: Acute Coronary SyndromeST-segment elevation myocardial infarctionMESH: FemaleTime FactorsMESH: RegistriesKaplan-Meier Estimate030204 cardiovascular system & hematologyMESH : Referral and ConsultationMESH: Proportional Hazards ModelsOlder patientsRisk FactorsMESH: Risk FactorsMESH : Female030212 general & internal medicineRegistriesMESH : Risk AssessmentMESH: AgedEjection fractionNon–ST-segment elevation myocardial infarctionMiddle Aged[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemMESH : Risk FactorsPatient DischargeTreatment OutcomeFemaleFranceMESH : Time FactorsMESH : MaleMESH : Treatment OutcomeMESH: Multivariate AnalysisMESH : Kaplan-Meier EstimateMESH: Referral and ConsultationInternal medicineInfarctus du myocarde sans sus-décalage du segment STmedicineIn patientcardiovascular diseasesMedical prescriptionMortalityRéadaptation cardiaqueMESH : FranceProportional Hazards Modelsbusiness.industryInfarctus du myocarde avec sus-décalage du segment STMESH: Time FactorsMESH : Multivariate AnalysisMESH: MaleMESH: Prospective StudiesSurgeryMESH: FranceInfarctus du myocarde aiguMultivariate AnalysisMESH : Myocardial InfarctionbusinessMESH : RegistriesFollow-Up Studies
researchProduct

Orofacial reactivity to the sight and smell of food stimuli. Evidence for anticipatory liking related to food reward cues in overweight children.

2012

International audience; Whether food liking may be a risk factor of overconsumption and overweight/obesity remains a controversial issue. So far, most studies used subjective reports to assess consummatory behavior, approaches that might overlook subtle or implicit hedonic changes to sensory properties of foods. Therefore, we used a cue-exposure approach by recording different measures of hedonic processes (orofacial reactivity, self-rated pleasantness, food preference) in 6-11 years old overweight (n=20) and normal-weight (n=20) children. Children were exposed to the smell and sight of high and low-energy density food stimuli and to non-food stimuli during pre- and post-prandial states. Th…

MaleMESH: Facial Expression030309 nutrition & dietetics[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionMESH : Vision OcularMESH : OverweightMESH: Energy IntakeOverweighteating behaviorDevelopmental psychologyBody Mass Index0302 clinical medicineMESH : ChildMESH: ChildMESH: SmellMESH : FemaleOvereatingReactivity (psychology)ChildGeneral Psychology0303 health sciencesNutrition and DieteticsMESH : Food Preferencesdigestive oral and skin physiologyMESH : Feeding BehaviorAnticipationMESH : HyperphagiaFacial ExpressionSmellCategorizationMESH: Feeding BehaviorFemalesensory cueMESH: Hyperphagiamedicine.symptomMESH : FoodPsychologySocial psychologyMESH: FoodhedonicMESH: Anticipation PsychologicalMESH : Maleoverweight childreward sensitivity030209 endocrinology & metabolismpleasureHyperphagiaSatiationMESH : Facial Expressionfacial reactivityMESH: Body Mass Index03 medical and health sciencesFood PreferencesRewardmedicineHumansMESH: Vision OcularMESH: OverweightMESH: Food PreferencesSensory cueVision OcularMESH : Anticipation PsychologicalMESH: RewardFacial expressionMESH: HumansMESH: SatiationMESH : HumansMESH : Energy IntakeFeeding BehaviorOverweightmedicine.diseaseAnticipation PsychologicalObesityMESH: MalebmiMESH : Body Mass IndexFoodfood likingMESH : SmellMESH : RewardEnergy IntakeMESH: Female[SDV.AEN]Life Sciences [q-bio]/Food and NutritionMESH : Satiation
researchProduct

A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARα-mediated upregulation of SREBP-2 target genes in the liver.: ThB …

2011

International audience; Peroxisomal 3-ketoacyl-CoA thiolase B (Thb) catalyzes the final step in the peroxisomal β-oxidation of straight-chain acyl-CoAs and is under the transcription control of the nuclear hormone receptor PPARα. PPARα binds to and is activated by the synthetic compound Wy14,643 (Wy). Here, we show that the magnitude of Wy-mediated induction of peroxisomal β-oxidation of radiolabeled (1-(14)C) palmitate was significantly reduced in mice deficient for Thb. In contrast, mitochondrial β-oxidation was unaltered in Thb(-/-) mice. Given that Wy-treatment induced Acox1 and MFP-1/-2 activity at a similar level in both genotypes, we concluded that the thiolase step alone was respons…

MaleMESH: HepatomegalyPalmitatesMESH : PyrimidinesMESH : Gene DeletionBiochemistryelement-binding proteinsMESH : Acetyl-CoA C-AcyltransferaseMiceMESH: Up-RegulationMESH: AnimalsMESH : Up-RegulationMESH: Lipid Metabolism0303 health sciencesMESH : Gene Expression RegulationThiolase030302 biochemistry & molecular biologyGeneral MedicineMESH : HepatomegalyUp-Regulationzellweger-syndromePeroxisome ProliferatorsMESH: Peroxisome ProliferatorsHepatomegalySterol Regulatory Element Binding Protein 2peroxisomal 3-ketoacyl-CoA thiolase BMESH: Mitochondria3-oxoacyl-coa thiolaseLathosterolfatty-acid oxidationrat-liverMESH: Sterol Regulatory Element Binding Protein 203 medical and health sciencesMESH : Sterol Regulatory Element Binding Protein 2HumansPPAR alphaMESH : Peroxisome Proliferators[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular BiologyPPARaVLAGMESH : Oxidation-ReductionFatty Acid Oxidation.MESH: HumansCholesterolMESH : HumanscholesterolLipid MetabolismMESH: PeroxisomesSterol regulatory element-binding proteinchemistryMESH: PyrimidinesCholesterol; Micro-array analysis; Peroxisomal 3-ketoacyl-CoA thiolase B; PPARα and SREBP-2; Wy14643Fatty Acid OxidationGene DeletionMESH: LiverMESH: Oxidation-ReductionMESH: Signal TransductionMESH: Mice KnockoutVoeding Metabolisme en Genomicachemistry.chemical_compoundMESH: CholesterolMESH : Lipid MetabolismWy14MESH : PalmitatesMESH: PPAR alphaMESH : CholesterolMice Knockoutneuronal migration643PeroxisomeAcetyl-CoA C-AcyltransferaseMESH: Gene Expression RegulationMetabolism and GenomicsMitochondriaLiverBiochemistryMicro-array analysisMetabolisme en GenomicaACOX1Nutrition Metabolism and GenomicsMESH : MitochondriaOxidation-ReductionSignal Transductionacyl-coa oxidasecholesterol-synthesisMESH : MaleMESH : PPAR alphaPeroxisome ProliferationPPARα and SREBP-2Biologybeta-oxidationVoedingproliferator-activated receptorsMESH : MicePeroxisomesAnimals[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyMESH: Mice030304 developmental biologySCP2NutritionMESH : Signal TransductionMESH : LiverMESH: PalmitatesMESH: MalePyrimidinesMESH: Acetyl-CoA C-AcyltransferaseGene Expression RegulationMESH: Gene DeletionMESH : Mice KnockoutMESH : AnimalsMESH : Peroxisomes
researchProduct

Sensitivity to change of two depression rating scales for stroke patients.

2010

Objective: To assess the sensitivity to change of two depression scales for stroke patients: the Aphasic Depression Rating Scale (ADRS), which is a 9-item external assessment, and the Visual Analog Mood Scale (VAMS), which is a visual self-assessment scale. Patients: Forty-nine stroke patients admitted to two rehabilitation units. Methods: Symptoms of depression were assessed twice at a one-month interval (D0—D30) using the ADRS, the VAMS, and by a trained psychologist (PSY). Sensitivity to change was assessed by effect size and standardized response mean. A one-way ANOVA on ranks was performed to determine if the scales distinguished between deteriorated, stable and improved patient statu…

MaleMESH: Psychiatric Status Rating ScalesMESH : StrokeStroke patientmedicine.medical_treatmentMESH: Depressive DisorderMESH : AgedMESH : Analysis of VarianceSeverity of Illness IndexMood scale[ SDV.NEU.SC ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences0302 clinical medicineMESH : Female030212 general & internal medicineDepression (differential diagnoses)MESH: AgedMESH : AphasiaRehabilitationMESH: Middle AgedRehabilitationStroke Rehabilitation[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesMiddle AgedMESH : AdultStrokeFemaleMESH : Severity of Illness IndexPatient statusMESH : Sensitivity and SpecificityMESH : Psychiatric Status Rating ScalesPsychologyClinical psychologyAdultmedicine.medical_specialtyMESH : MalePhysical Therapy Sports Therapy and RehabilitationSensitivity and SpecificityMESH: Stroke03 medical and health sciencesRating scaleMESH: Severity of Illness IndexMESH: Analysis of VarianceAphasiamedicineHumansMESH : Middle AgedSensitivity to changeAgedMESH: AphasiaPsychiatric Status Rating ScalesAnalysis of VarianceDepressive DisorderMESH: HumansMESH : HumansMESH: AdultMESH: Sensitivity and SpecificityMESH: MaleMESH : Depressive DisorderPhysical therapyMESH: Female030217 neurology & neurosurgery
researchProduct